Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Carboplatin 133 pembrolizumab 132 Cisplatin 120 Paclitaxel 104 Gemcitabine 88 Specimen Handling 82 Magnetic Resonance Spectroscopy 82 Docetaxel 74 Dexamethasone 60 Cyclophosphamide 60 Pemetrexed 57 Bevacizumab 56 durvalumab 55 Capecitabine 55 Doxorubicin 52 Radiotherapy 51 Oxaliplatin 50 Fluorouracil 49 Radiation 48 Leucovorin 44 Rituximab 43 Vincristine 42 Lenalidomide 40 Etoposide 39 atezolizumab 37 Nivolumab 37 Letrozole 36 130-nm albumin-bound paclitaxel 32 Prednisone 31 Irinotecan 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × oprelvekin × 90 days × Clear all

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡